Fabrice Hamaide
Analyst · ROTH. Your line is open
Thanks, Yaniv and good afternoon, everyone. Here are the operational performance details of our second quarter. For the second quarter of 2020, net revenue increased 96.9% to $59.8 million from $30.4 million in the year ago period. The gain was primarily attributable to increased direct sales volume of new products launched since the second half of 2019, which contributed $23.1 million in net revenues and historical products, as well as the wholesale revenue of PPE products which contributed $5.7 million. We experienced a sales interruption on our hOmeLabs dehumidifiers for three weeks in June, while we resolve an inquiry from the EPA, and estimate a $4 million missed opportunity in sales during the quarter as a result. Since early July, we have resolved the inquiry and resumed selling our hOmeLabs dehumidifiers. Gross margin for the second quarter increased 135% from a year ago to 46.2% and was up 600 basis points on a sequential basis. The sequential improvement in gross margin was due to improved product unit economics, stemming from both lower cogs and higher sales prices, as more products reached a sustained phase partially offset by the wholesale PPE sales, which carry a slightly lower gross margin. In terms of our product segments, launch sustain phase, liquidation and other, overall, our sustained revenue grew to $44 million and grew 175% as compared to first quarter 2020. In Q2 2020, we launched eight products on top of the 16 that we launched in Q1 2020, bringing the total for the first half of 2020 to 24. Our launch revenue for Q2 2020 was $5.7 million. As such revenue remained essentially flat as we continue to work on our market segmentation and building a repeatable funnel and conversion process. Finally, for Q2 2020, liquidation and other revenue was approximately $3.9 million and $5.9 million respectively versus our first quarter 2020 liquidation and other revenue of $2.2 million and $0.2 million respectively. The increase in other revenue is a result of wholesale PPE revenues of $5.7 million to states and other government entities. Our overall Q2 2020 contribution margin was 16.8%, a significant improvement versus the prior year’s 5.7% and compared to our Q1 2020 contribution margin of negative 2.9%, a year-over-year improvement as well as a sequential improvement were driven by improved productivity unit economics, coming from higher average selling prices, lower cogs and lower fulfillment costs, increased sustained revenue mix, and higher sale prices of the launch revenue as they reach the end of the launch phase. Our sustained business drove the majority of our positive CM at 19.8%. Fixed costs for Q2 2020 were $6.6 million compared to $5.4 million in the prior year quarter, representing an increase due to one-time cost of severance, recruiting and bonus accrual. As a percentage of net revenue, fixed costs decreased to 11.1% from 17.8% in the year ago quarter, and compared with $5.7 million, or 22.1% of net revenues in first quarter 2020. Improvement in fixed cost margin highlights our ability to launch new products and grow revenue, while keeping fixed costs essentially flat. Thanks to the high degree of automation of our business model. This is the first quarter of adjusted EBITDA profitability, of course sooner than what we had previously anticipated. Adjusted EBITDA for the second quarter of 2020 improved to $3.4 million from the loss of $3.7 million in the second quarter of 2019. And also saw sequential improvement from a loss of $6.4 million in the first quarter of 2020. We'd highlight that our GDP profitability is a result of the growth in our business from both our existing products and new product launches, combined with continued improvements in our unit economics, and our fixed operating expense leverage, thanks to the high degree of automation of the business model. Turning to the balance sheet. As of June 30, 2020 we had cash of $17.2 million, compared with $14.1 million at the end of March 31 2020. This sequential increase in cash while at the same time reducing our debt is the result of improved margins and seasonality impact on sales and inventory turns. Cash generated from the operating activities for the second quarter was $8.2 million compared to cash used in operating activities of $17.1 million in the first quarter of 2020. Second quarter 2020 operating activities were impacted by decreased cash operating loss, and a net increase in cash from working capital, as we turn our inventory on hand. Overall, cash generated was 3.1 million, compared to cash burn of $16.3 million in the first quarter of 2020 due to increased sales at higher margins, controlled fixed costs and working capital. As of June 30, 2020 our total debt which consists of borrowings under our revolving credit facility in our $15 million term loan decreased to $31.9 million compared to $35.1 million as of March 2020 and compared to $37.9 million dollars at the end of December 31 2019. This decrease is a direct reflection of our planned seasonality driven increase inventory from Q1 to prepare for the seasonal increase in sales of Q2 and Q3. In terms of outlook for new products in the third quarter 2020, we expect to launch approximately 10 new products. We could experience some limited inventory stock outs in the quarter, as we work to absorb the faster growth rates of Q2 and forecast of Q3. To complete the key takeaways of the quarter are faster growth, more profitability, generating cash. For 2020, we reiterate our June 4th updated guidance and continue to expect net revenue to be in the range of $170 million to $180 million driven primarily by continued growth of our existing product portfolio our PPE efforts and the positive contribution from new products launched in 2020 and late in 2019. The company expects positive adjusted EBITDA in the third and fourth quarter of 2020 and in addition, expects positive adjusted EBITDA on a full year basis in 2020, a year earlier than anticipated. With that, I’ll turn it back to the operator to open the call for your questions.